![]() |
市场调查报告书
商品编码
1863644
全球超音波设备市场:按技术、显示类型、便携性、应用、最终用户和地区划分-市场规模、产业趋势、机会分析和预测(2025-2033 年)Global Ultrasound Devices Market: By technology, Display Type, Portability, Application, End Users, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033 |
||||||
超音波设备市场目前正经历着以稳定成长和技术创新为特征的转型期。 2024 年,该市场规模约为 93.5 亿美元,预计到 2033 年将显着增长至约 141.8 亿美元。这一增长反映了 2025 年至 2033 年预测期内 4.74% 的复合年增长率 (CAGR),凸显了各个医疗领域对超音波技术日益增长的需求。
推动超音波设备市场发展的几个关键趋势正在发挥作用。其中最具影响力的发展之一是将人工智慧 (AI) 整合到超音波系统中。人工智慧可以增强影像分析能力、自动测量,并帮助临床医生更快、更准确地做出诊断,从而改善患者预后并提高工作流程效率。与人工智慧同步发展,便携式床边超音波(POCUS)设备的普及率也显着提高。
目前,超音波市场正经历策略性重组,这主要得益于与领先技术公司建立新的合作伙伴关係,以及主要参与者之间日益增强的垂直整合。随着越来越多的公司寻求透过先进技术和营运效率来获得竞争优势,这些变化正在重塑竞争格局。一个值得关注的例子是,Sonomind 在 2025 年 10 月完成了 300 万欧元(约 353 万美元)的融资,用于进一步开发其神经调控超音波设备。这笔资金包括来自 Critical Path Ventures 的 200 万欧元(约 235 万美元)种子轮融资,以及透过法国政府 "法国 2030" 计画获得的 100 万欧元额外投资。
为了因应这些不断变化的市场动态,超音波产业的中小型企业正在采用 API 优先策略,以保持竞争力并保持市场地位。透过专注于开发能够与其他医疗技术无缝整合的应用程式介面 (API),我们旨在提供灵活、可互通的解决方案,使其能够顺利融入现有的临床工作流程。例如,Sonio 于 2025 年 8 月在美国发布了一条专为孕产妇护理设计的新型超音波产品线。这些产品强调与医疗服务提供者现有技术体系的便利集成,旨在提高诊断准确性和营运效率。
核心成长驱动因子
全球慢性病(尤其是心血管疾病、癌症和肝病)的日益增多,推动了对超音波等精准、即时诊断工具的需求成长。这些慢性病在全球造成了沉重且不断增长的健康负担,而早期准确的检测方法对于改善患者预后至关重要。根据世界卫生组织 (WHO) 发布的 "2024 年全球疾病负担报告" ,光是心血管疾病 (CVD) 每年就导致约 2,050 万人死亡,凸显了製定有效诊断策略的紧迫性。 早期诊断这些疾病至关重要,及时介入可以显着降低死亡率,并改善全球数百万患者的生活品质。
新机会与趋势
在后疫情时代,远距医疗已稳固确立其作为医疗服务基础的地位。无线超音波市场在克服地域限制和专家短缺方面发挥关键作用。远端超音波技术已成为一种创新解决方案,使医疗服务提供者能够在专家资源有限的偏远和医疗资源匮乏地区提供诊断影像服务。根据2024年发表在 "美国医学会杂誌" (JAMA)上的一项研究,美国约有68%的乡村诊所已在其产前护理计画中实施了远距超音波。这种广泛应用主要得益于FDA核准的无线超音波设备的普及。
优化障碍
持续存在的技能差距对市场上超音波设备的有效利用构成重大威胁,可能会削弱其在临床环境中的潜在益处。根据美国超音波心臟学会2024年的一项调查,约43%的基层医疗服务提供者表示,即使完成了基础培训,他们仍然缺乏操作高级超音波系统的信心。这种信心的缺乏反映了掌握日益复杂的超音波技术所面临的更广泛挑战,这些技术需要的不仅仅是基础知识才能发挥最佳效用。随着超音波设备变得越来越复杂和多功能,现有技术与使用者熟练程度之间的差距越来越大,这可能会限制超音波成像的准确性和临床价值。
The ultrasound devices market is currently experiencing a transformative phase characterized by steady growth and technological innovation. Valued at approximately US$ 9.35 billion in 2024, the market is projected to expand significantly, reaching an estimated US$ 14.18 billion by 2033. This growth reflects a compound annual growth rate (CAGR) of 4.74% over the forecast period from 2025 to 2033, highlighting the increasing demand for ultrasound technology across various healthcare sectors.
Several key trends are driving this evolution within the ultrasound devices market. One of the most impactful developments is the integration of artificial intelligence (AI) into ultrasound systems. AI enhances image analysis, automates measurements, and assists clinicians in making faster and more accurate diagnoses, thereby improving patient outcomes and workflow efficiency. Alongside AI, there is a notable surge in the adoption of portable point-of-care ultrasound (POCUS) devices.
The ultrasound devices market is currently undergoing significant strategic realignments, driven by new partnerships with major technology companies and increasing vertical integration among key players. These shifts are transforming the competitive landscape, as companies seek to leverage advanced technologies and streamline their operations to gain an edge. A notable example occurred in October 2025 when Sonomind secured a substantial investment of €3 million (approximately $3.53 million) aimed at advancing its Neuromodulation Ultrasound Device. This funding included €2 million ($2.35 million) in seed capital from Critical Path Ventures alongside an additional €1 million provided through the French government's France 2030 initiative.
In response to these evolving market dynamics, smaller players in the ultrasound device industry are adopting API-first strategies to remain competitive and relevant. By focusing on developing application programming interfaces (APIs) that facilitate seamless integration with other healthcare technologies, these companies aim to provide more flexible, interoperable solutions that fit smoothly into existing clinical workflows. For instance, in August 2025, Sonio introduced a new suite of ultrasound offerings specifically designed for maternal care in the United States. These products emphasize ease of integration with current technology stacks used by healthcare providers, aiming to enhance both diagnostic accuracy and operational efficiency.
Core Growth Drivers
The global rise in chronic diseases, especially cardiovascular disorders, cancers, and liver conditions, is fueling an increasing demand for accurate and real-time diagnostic tools such as ultrasound. These chronic illnesses represent a significant and growing health burden worldwide, necessitating early and precise detection methods to improve patient outcomes. The World Health Organization's 2024 Global Burden of Disease Report highlights that cardiovascular diseases (CVDs) alone are responsible for approximately 20.5 million deaths annually, underscoring the urgent need for effective diagnostic strategies. Early diagnosis of such conditions is critical, as timely intervention can substantially reduce mortality rates and improve quality of life for millions of patients globally.
Emerging Opportunity Trends
The post-pandemic era has firmly established telemedicine as a fundamental component of healthcare delivery, with the wireless ultrasound devices market playing a crucial role in addressing geographic and specialist shortages. Tele-ultrasound technology has emerged as a transformative solution, enabling healthcare providers to extend diagnostic imaging services to remote and underserved areas where access to specialists is limited. According to a 2024 study published in JAMA, approximately 68% of rural clinics in the United States have incorporated tele-ultrasound into prenatal care programs. The availability of FDA-approved wireless ultrasound devices largely drives this widespread adoption.
Barriers to Optimization
A persistent skills gap poses a significant threat to the effective utilization of ultrasound devices in the market, undermining their potential benefits in clinical practice. According to a 2024 survey conducted by the American Society of Echocardiography, nearly 43% of primary care providers reported lacking confidence in operating advanced ultrasound systems, even after completing basic training. This lack of confidence reflects broader challenges in mastering increasingly sophisticated ultrasound technologies, which require more than rudimentary knowledge for optimal use. As ultrasound devices become more complex and feature-rich, the gap between available technology and user proficiency widens, potentially limiting the accuracy and clinical value of ultrasound imaging.
By Technology, diagnostic ultrasound technology holds a commanding dominance in the ultrasound devices market, capturing an impressive 92.4% share. This overwhelming preference is largely due to its non-invasive nature, which ensures patient safety while delivering high-quality imaging. Unlike other diagnostic methods that may involve radiation or invasive procedures, ultrasound uses sound waves to visualize internal structures, making it an ideal choice for repeated use and monitoring without risk. This safety profile has made diagnostic ultrasound a cornerstone in medical imaging, widely trusted across various healthcare specialties.
By Display Type, color ultrasound devices dominate the ultrasound devices market, commanding an impressive 90.9% share, largely because of their superior diagnostic accuracy compared to traditional grayscale systems. The ability to visualize blood flow, tissue vascularity, and movement in real-time with vibrant color imaging provides clinicians with critical information that enhances diagnostic confidence and precision. This advanced visualization capability is particularly valuable in complex cases where subtle differences in tissue characteristics or blood flow patterns can influence clinical decisions and patient outcomes.
By Portability, cart-based ultrasound systems continue to dominate the market with a substantial 57.31% share, maintaining their status as essential equipment in emergency rooms (ER) and intensive care units (ICU). Their robust performance, large display screens, and advanced imaging capabilities make them the preferred choice for critical care environments where quick and accurate diagnostics are paramount. A notable example of innovation within this category is Philips' Lumify system integrated with Reacts(R) tele-guidance technology.
By Application, radiology holds a commanding 29.6% share of the ultrasound devices market, largely propelled by the growing adoption of elastography technology. Elastography, a non-invasive imaging technique that measures tissue stiffness, has revolutionized diagnostic capabilities within radiology by providing more precise assessments of various conditions. This advancement has contributed significantly to radiology's leadership position in the ultrasound market, offering clinicians enhanced tools to improve patient outcomes while reducing the need for invasive procedures.
By Technology
By Display Type
By Portability
By Application
By End User
By Region
Geography Breakdown